Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,431 | 772 | 98.3% |
| Education | $208.94 | 8 | 1.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,486 | 109 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,345 | 75 | $0 (2024) |
| Amgen Inc. | $1,241 | 73 | $0 (2024) |
| Lilly USA, LLC | $931.11 | 53 | $0 (2024) |
| ABBVIE INC. | $646.47 | 43 | $0 (2024) |
| PFIZER INC. | $616.02 | 41 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $577.32 | 39 | $0 (2024) |
| GlaxoSmithKline, LLC. | $571.07 | 43 | $0 (2024) |
| Astellas Pharma US Inc | $566.02 | 32 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $456.42 | 22 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,780 | 98 | Lilly USA, LLC ($234.98) |
| 2023 | $1,895 | 110 | Lilly USA, LLC ($200.05) |
| 2022 | $1,758 | 107 | Novo Nordisk Inc ($267.75) |
| 2021 | $1,330 | 81 | Novo Nordisk Inc ($312.39) |
| 2020 | $607.49 | 37 | AstraZeneca Pharmaceuticals LP ($137.07) |
| 2019 | $1,457 | 91 | Amgen Inc. ($296.05) |
| 2018 | $1,997 | 125 | AstraZeneca Pharmaceuticals LP ($374.16) |
| 2017 | $1,815 | 131 | AstraZeneca Pharmaceuticals LP ($183.34) |
All Payment Transactions
780 individual payment records from CMS Open Payments — Page 1 of 32
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Diabetes Care | ||||||
| 12/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.18 | General |
| Category: RESPIRATORY | ||||||
| 12/09/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: DIABETES | ||||||
| 12/03/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $25.08 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/22/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $19.14 | General |
| Category: Bone Health | ||||||
| 11/20/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.80 | General |
| Category: Obesity | ||||||
| 11/14/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $30.13 | General |
| Category: NEUROLOGY | ||||||
| 11/14/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.37 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $22.75 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/06/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/06/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN | Food and Beverage | In-kind items and services | $14.71 | General |
| Category: Gastroenterology | ||||||
| 11/04/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Biological | ||||||
| 11/01/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $1.99 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/31/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.54 | General |
| Category: Oncology | ||||||
| 10/31/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $8.29 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/22/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: Obesity | ||||||
| 10/14/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $16.71 | General |
| Category: Endocrinology | ||||||
| 10/11/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $21.04 | General |
| Category: PAIN | ||||||
| 10/10/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: Diabetes | ||||||
| 10/07/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.51 | General |
| Category: Biological | ||||||
| 10/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: RESPIRATORY | ||||||
| 09/30/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 35 | 2,306 | 3,535 | $378,466 | $167,602 |
| 2022 | 27 | 2,105 | 3,228 | $327,646 | $146,954 |
| 2021 | 24 | 1,761 | 2,552 | $285,298 | $128,629 |
| 2020 | 33 | 2,419 | 3,140 | $342,100 | $143,931 |
All Medicare Procedures & Services
119 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 383 | 919 | $158,600 | $80,425 | 50.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 214 | 214 | $36,808 | $27,777 | 75.5% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 56 | 248 | $27,916 | $11,507 | 41.2% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 29 | 29 | $14,960 | $7,882 | 52.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 29 | 30 | $7,921 | $3,915 | 49.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 51 | 55 | $5,644 | $3,410 | 60.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 168 | 168 | $10,068 | $3,137 | 31.2% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 20 | 20 | $4,266 | $2,991 | 70.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 95 | 95 | $5,556 | $2,871 | 51.7% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 40 | 83 | $4,565 | $2,868 | 62.8% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 146 | 235 | $13,419 | $2,222 | 16.6% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 25 | 25 | $3,000 | $1,798 | 59.9% |
| 87635 | Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2023 | 35 | 36 | $5,400 | $1,762 | 32.6% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 74 | 74 | $8,140 | $1,627 | 20.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 142 | 150 | $11,834 | $1,450 | 12.3% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 47 | 47 | $2,784 | $1,427 | 51.3% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 31 | 32 | $15,616 | $1,238 | 7.9% |
| 90471 | Administration of vaccine | Office | 2023 | 73 | 82 | $2,560 | $1,157 | 45.2% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2023 | 46 | 85 | $3,188 | $1,050 | 32.9% |
| 81003 | Automated urinalysis test | Office | 2023 | 268 | 458 | $9,190 | $996.69 | 10.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 13 | 13 | $1,703 | $985.53 | 57.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 53 | 84 | $3,276 | $897.64 | 27.4% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 48 | 48 | $4,704 | $896.16 | 19.1% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 16 | 16 | $5,200 | $836.22 | 16.1% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 14 | 14 | $1,120 | $569.66 | 50.9% |
About Dr. David Hall, M.D
Dr. David Hall, M.D is a Family Medicine healthcare provider based in Alpharetta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1962486381.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Hall, M.D has received a total of $12,640 in payments from pharmaceutical and medical device companies, with $1,780 received in 2024. These payments were reported across 780 transactions from 61 companies. The most common payment nature is "Food and Beverage" ($12,431).
As a Medicare-enrolled provider, Hall has provided services to 8,591 Medicare beneficiaries, totaling 12,455 services with total Medicare billing of $587,117. Data is available for 4 years (2020–2023), covering 119 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Alpharetta, GA
- Active Since 11/30/2005
- Last Updated 05/10/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1962486381
Products in Payments
- FARXIGA (Drug) $871.03
- JARDIANCE (Drug) $762.89
- Saxenda (Drug) $418.80
- MOUNJARO (Drug) $418.25
- Aimovig (Biological) $374.83
- Prolia (Biological) $354.02
- Wegovy (Drug) $335.06
- Vascepa (Drug) $326.76
- EVENITY (Biological) $325.45
- Ozempic (Drug) $296.32
- NURTEC ODT (Drug) $286.51
- CHANTIX (Drug) $268.78
- LEQVIO (Drug) $244.41
- VRAYLAR (Drug) $230.59
- TRELEGY ELLIPTA (Drug) $225.69
- FREESTYLE LIBRE 3 (Device) $201.26
- Rybelsus (Drug) $183.98
- UBRELVY (Drug) $178.88
- Myrbetriq (Drug) $176.87
- ENTRESTO (Drug) $173.87
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Alpharetta
Mark Glodener, Md, MD
Family Medicine — Payments: $19,661
Richard Shack, Md, MD
Family Medicine — Payments: $15,635
Mrs. Arielle Sullivan-Harris, M.d, M.D
Family Medicine — Payments: $14,109
Dr. David Boaz, M.d, M.D
Family Medicine — Payments: $13,802
Dr. Satishkumar Ganjam, Md, MD
Family Medicine — Payments: $12,813
Terence Moraczewski, M.d, M.D
Family Medicine — Payments: $12,451